Patent: 10,251,871
✉ Email this page to a colleague
Summary for Patent: 10,251,871
Title: | Compositions and methods for treatment of edema |
Abstract: | Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-.beta.1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically. |
Inventor(s): | Mehrara; Babak (Chappaqua, NY), Gardenier; Jason (Altona, NY), Savetsky; Ira (Cedarhurst, NY), Aras; Omer (New York, NY) |
Assignee: | Memorial Sloan Kettering Cancer Center (New York, NY) |
Application Number: | 15/549,156 |
Patent Claims: | see list of patent claims |
Details for Patent 10,251,871
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 05/12/1998 | ⤷ Try a Trial | 2035-02-05 |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 01/02/2003 | ⤷ Try a Trial | 2035-02-05 |
Eisai, Incorporated | ONTAK | denileukin diftitox | Injection | 103767 | 02/05/1999 | ⤷ Try a Trial | 2035-02-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |